Sneak Preview: Clinical Trial Policies Top IP As Biggest Obstacle To Indian Innovation
This article was originally published in PharmAsia News
Executive Summary
Despite recent news flow focused on a challenging patent environment, India’s pharma market is expected to grow 13% annually to reach $45 billion by 2020, according to a McKinsey report to be released June 21 during the annual U.S.-India BioPharma & Healthcare Summit in Boston.